Gray Susannah

Gray Susannah is listed in filings as Director at Theravance Biopharma, Inc.. This profile follows SEC Form 4 activity through Jun 16, 2026, including 7 public disclosures. Recent filings connect the profile to Theravance Biopharma, Inc. (TBPH), MARAVAI LIFESCIENS HLDGS INC (MRVI), and AnaptysBio, Inc. (ANAB). The current snapshot covers public activity from May 21, 2025 to Jun 16, 2026. Reported amounts are shown as $222.9K to $192.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.